glp 1 receptor drugs GLP-1 Agonists as Treatments for Type 2 Diabetes Comparing Ozempic, Wegovy and Other
Description
Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al
Tirzepatide as an insulin sensitizer
Neff, K
May 21, 2025 Subscribe Never miss out on new content from Dr
Evolution of Longer-Acting Formulations Once the chemistry was established, the next mission scientists faced was to make GLP-1 agonists last longer in the body, so patients wouldnt have to keep poking themselves like a pincushion
While the ADJUNCT TWO also reported an increased rate ratio of symptomatic hypoglycemia of 1.33 on 1.2 mg liraglutide, events were not significantly different with the 1.8 mg dose in that study
